Able to kill COVID-19 in 15 seconds, Nanocyn, a hospital-grade disinfecting solution produced by Adelaide-based MicroSafe Care Australia, has received approval from the Therapeutic Goods Administration (TGA).
Compared to traditional products that can take between one and 10 minutes to kill viruses, Nanocyn claims it stands alone as the only natural disinfectant and sanitiser in the world that can kill COVID-19 within 15 seconds, and the only hospital-grade disinfectant of its kind in Australia that eliminates the virus so quickly.
It is also able to eliminate Norovirus (Gastro), Influenza, fungi and mould by up to 99.9999 per cent.
“Nanocyn is a game-changer for any hospital, aged care or health service, transport-provider, business, school, tourism or hospitality venue and even office space wanting to ensure their premises are COVID-safe, not just from a pandemic point of view but also having been disinfected with a product that does not leave any harmful residues behind that could cause other health issues in the long-term,” said MicroSafe managing director Matt Seifert.
Nanocyn can also be used as a fogging agent in a variety of sizeable locations, such as commercial buildings, schools, hospitals, and health and aged care facilities.
Certified by all major aviation manufacturers, the product can clean aircraft without damaging materials.
Coming in a range of three sizes, the hospital-grade disinfectant is registered with the TGA and entered into the Australian Register of Therapeutic Goods (ARTG).
It is also the only disinfectant to also be certified by Good Environmental Choice Australia.
“It’s the fastest-acting product in Australia, leaves no residue and is non-toxic, which means it’s safe for those whose immune systems are compromised,” said Seifert.
“The TGA additional approval has also been timely as we know states will be re-opening borders before Christmas.
“Ensuring COVID-19 can be eliminated quickly in public areas will be reassuring for millions of people.”
Updated at 12:43pm AEDT on 13 August.
Enjoyed this article?
Don't miss out on the knowledge and insights to be gained from our daily news and features.
Subscribe today to unlock unlimited access to in-depth business coverage, expert analysis, and exclusive content across all devices.
Support independent journalism and stay informed with stories that matter to you.